Candidate gene analysis in premature pubarche and adolescent hyperandrogenism

被引:46
作者
Witchel, SF [1 ]
Smith, R [1 ]
Tomboc, M [1 ]
Aston, CE [1 ]
机构
[1] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Pediat Endocrinol, Pittsburgh, PA 15213 USA
关键词
premature pubarche; polycystic ovary syndrome; hyperandrogenism; precocious puberty; genetic variation; hyperinsulinemia/insulin resistance;
D O I
10.1016/S0015-0282(00)01798-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To identify genetic markers associated with premature pubarche in children and hyperandrogenism in adolescent girls. Design: Association study. Setting: Academic research environment. Patient(s): Forty children with premature pubarche (PP), 29 adolescent girls with hyperandrogenism (HA), and 15 healthy control women. Intervention(s): None. Main Outcome Measure(s): Genetic variations at five loci selected because of known associations with hyperandrogenism, insulin resistance, hyperinsulinemia, or obesity. Result(s): Heterozygosity for CYP21 mutations was identified in 14 of 40 (35%) PP, 8 of 29 (28%) HA, and 1 of 30 (3%) controls. Heterozygosity for HSD3B2 variants was identified in 3 of 40 (7.5%) PP, 5 of 29 (17%) HA, and 0/15 controls. Among the PP, 11 of 80 (14%), 5 of 80 (6%), and 7 of 80 (9%) alleles showed the IRS-1, GRL, and ADRB3 variants, respectively. Among the HA, 5 of 58 (8.6%), 3 of 58 (58), and 6 of 58 (10%) alleles showed the IRS-1, GRL, and ADRB3 variants, respectively. Among the control participants, variant allele frequency was 1 of 30 (3.3%) for IRS-1, 2 of 30 (6.6%) for GRL, and 2 of 30 (6.6%) for ADRB3. Conclusion(s): Our findings suggest that the development of PP and HA can be associated with the occurrence of multiple sequence variants at five susceptibility loci, especially steroidogenic enzyme genes. This approach offers a novel paradigm to investigate and identify the genetic factors relevant to polycystic ovary syndrome. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:724 / 730
页数:7
相关论文
共 56 条
[1]   Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index [J].
Allison, DB ;
Heo, M ;
Faith, MS ;
Pietrobelli, A .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (06) :559-566
[2]   A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling - Evidence from transfection studies [J].
Almind, K ;
Inoue, G ;
Pedersen, O ;
Kahn, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2569-2575
[3]   METABOLIC FEATURES OF POLYCYSTIC-OVARY-SYNDROME ARE FOUND IN ADOLESCENT GIRLS WITH HYPERANDROGENISM [J].
APTER, D ;
BUTZOW, T ;
LAUGHLIN, GA ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10) :2966-2973
[4]   ACCELERATED 24-HOUR LUTEINIZING-HORMONE PULSATILE ACTIVITY IN ADOLESCENT GIRLS WITH OVARIAN HYPERANDROGENISM - RELEVANCE TO THE DEVELOPMENTAL PHASE OF POLYCYSTIC OVARIAN SYNDROME [J].
APTER, D ;
BUTZOW, T ;
LAUGHLIN, GA ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :119-125
[5]   A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease [J].
Baroni, MG ;
D'Andrea, MP ;
Montali, A ;
Pannitteri, G ;
Barillà, F ;
Campagna, F ;
Mazzei, E ;
Lovari, S ;
Seccareccia, F ;
Campa, PP ;
Ricci, G ;
Pozzilli, P ;
Urbinati, G ;
Arca, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2975-2980
[6]   Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women [J].
Blanche, H ;
Vexiau, P ;
Clauin, S ;
LeGall, I ;
Fiet, J ;
Mornet, E ;
Dausset, J ;
BellanneChantelot, C .
HUMAN GENETICS, 1997, 101 (01) :56-60
[7]   INSULIN-RESISTANCE - INTERACTIONS BETWEEN OBESITY AND A COMMON VARIANT OF INSULIN-RECEPTOR SUBSTRATE-1 [J].
CLAUSEN, JO ;
HANSEN, T ;
BJORBAEK, C ;
ECHWALD, SM ;
URHAMMER, SA ;
RASMUSSEN, S ;
ANDERSEN, CB ;
HANSEN, L ;
ALMIND, K ;
WINTHER, K ;
HARALDSDOTTIR, J ;
BORCHJOHNSEN, K ;
PEDERSEN, O .
LANCET, 1995, 346 (8972) :397-402
[8]   Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome [J].
Cohen, DP ;
Stein, EM ;
Li, Z ;
Matulis, CK ;
Ehrmann, DA ;
Layman, LC .
FERTILITY AND STERILITY, 1999, 72 (02) :360-363
[9]  
Cotton RGH, 2000, HUM MUTAT, V15, P16, DOI 10.1002/(SICI)1098-1004(200001)15:1<16::AID-HUMU6>3.0.CO
[10]  
2-S